Document
IPR2020-01053, No. 2072 Exhibit - Dainippon Sumitomo Pharma Co, Ltd, Supplementary Financial Datafor Year Ended March 31, 2014 (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2072 Exhibit - Dainippon Sumitomo Pharma Co, Ltd, Supplementary Financial Datafor Year Ended March 31, 2014 (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 1057 Exhibit - Petitioners Demonstrative Exhibits (P.T.A.B. Aug. 9, 2021)
Cite Document
IPR2020-01053, No. 1057 Exhibit - Petitioners Demonstrative Exhibits (P.T.A.B. Aug. 9, 2021)
+ More Snippets
Document
IPR2020-01053, No. 1053 Exhibit - Claim Construction Brief at Federal Circuit (P.T.A.B. Jun. 10, 2021)
Cite Document
IPR2020-01053, No. 1053 Exhibit - Claim Construction Brief at Federal Circuit (P.T.A.B. Jun. 10, 2021)
+ More Snippets
Document
IPR2020-01053, No. 1056 Exhibit - Morrison (P.T.A.B. Jun. 10, 2021)
Cite Document
IPR2020-01053, No. 1056 Exhibit - Morrison (P.T.A.B. Jun. 10, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2098 Exhibit - Zhuo et al, Topiramate and Metformin Are Effective Add OnTreatments in Controlling Anti Psychotic Weight Gain (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2098 Exhibit - Zhuo et al, Topiramate and Metformin Are Effective Add OnTreatments in Controlling Anti Psychotic Weight Gain (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2073 Exhibit - Jancin, Newer Atypical Antipsychotics Draw Praise (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2073 Exhibit - Jancin, Newer Atypical Antipsychotics Draw Praise (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 1052 Exhibit - Claim Construction Brief in District Court (P.T.A.B. Jun. 10, 2021)
Cite Document
IPR2020-01053, No. 1052 Exhibit - Claim Construction Brief in District Court (P.T.A.B. Jun. 10, 2021)
+ More Snippets
Document
IPR2020-01053, No. 1051 Exhibit - Supplemental Declaration Dr Kosten, MD (P.T.A.B. Jun. 10, 2021)
Cite Document
IPR2020-01053, No. 1051 Exhibit - Supplemental Declaration Dr Kosten, MD (P.T.A.B. Jun. 10, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2135 Exhibit - Hummel et al, Clozapine as Add On Medication in the MaintenanceTreatment of Bipolar and Schizoaffective Disorder (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2135 Exhibit - Hummel et al, Clozapine as Add On Medication in the MaintenanceTreatment of Bipolar and Schizoaffective Disorder (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2001 Exhibit - History of the discovery and clinical introduction of chlorpromazine (P.T.A.B. Sep. 18, 2020)
Cite Document
IPR2020-01053, No. 2001 Exhibit - History of the discovery and clinical introduction of chlorpromazine (P.T.A.B. Sep. 18, 2020)
+ More Snippets
Document
IPR2020-01053, No. 2050 Exhibit - Lieberman et al, Effectiveness of Antipsychotic Drugs in Patientswith Chronic Schizophrenia (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2050 Exhibit - Lieberman et al, Effectiveness of Antipsychotic Drugs in Patientswith Chronic Schizophrenia (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2055 Exhibit - Pacher et al, Cardiovascular Side Effects of New Antidepressants andAntipsychotics (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2055 Exhibit - Pacher et al, Cardiovascular Side Effects of New Antidepressants andAntipsychotics (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2141 Exhibit - News Release FDA Approves Once Daily Latuda lurasidoneHCl for Treatment of Patients with Schizophrenia (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2141 Exhibit - News Release FDA Approves Once Daily Latuda lurasidoneHCl for Treatment of Patients with Schizophrenia (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2085 Exhibit - Ng Mak et al, Efficacy and Metabolic Effects of Lurasidone VersusBrexpiprazole in Schizophrenia (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2085 Exhibit - Ng Mak et al, Efficacy and Metabolic Effects of Lurasidone VersusBrexpiprazole in Schizophrenia (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2048 Exhibit - Symbyax�� Label (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2048 Exhibit - Symbyax�� Label (P.T.A.B. Mar. 11, 2021)
+ More Snippets